The Human Cancer PrimaCell™ 14: Rectal Tumor Cells is for rapid (7-10 days) isolation and growth of human rectal tumor cells from human rectal tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 6-8 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 14 System (Cat No. 2-96037):
Human Cancer PrimaCell™ 14: Rectal Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 14: Rectal Tumor Cells
Human Cancer OptiTDS™ 14: Tissue Dissociation System
Human Cancer PrimaCell™ 14: Rectal Tumor Cells Growth Medium
Human Cancer PrimaCell™ 14: Rectal Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Yamazaki Y, Aono I, Ohya T, Shibahara T, Kadota K. Gastroduodenal adenocarcinomas and rectal adenoma in a cougar (Felis concolor) infected with Helicobacter-like organisms and spirochetes. J Vet Med Sci. 2002 Feb;64(2):149-53.
[2] Patel JR, Daniel J, Mathan M, Mathan VI. Isolation and identification of enteroviruses from faecal samples in a differentiated epithelial cell line (HRT-18) derived from human rectal carcinoma. J Med Virol. 1984;14(3):255-61.